FDA Inspection 1110774 — BrainStorm Cell Therapeutics, Inc
The FDA completed an inspection of BrainStorm Cell Therapeutics, Inc on November 5, 2019 in Hackensack, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 5, 2019
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Hackensack, NJ (United States)
Additional Details
Sponsor, Contract Research Organization